Matrix Trust Co Buys 57 Shares of UnitedHealth Group Incorporated (NYSE:UNH)

Matrix Trust Co grew its stake in UnitedHealth Group Incorporated (NYSE:UNH) by 1.6% during the 1st quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 3,691 shares of the healthcare conglomerate’s stock after acquiring an additional 57 shares during the quarter. Matrix Trust Co’s holdings in UnitedHealth Group were worth $1,933,000 at the end of the most recent quarter.

A number of other hedge funds also recently bought and sold shares of UNH. Norges Bank purchased a new stake in shares of UnitedHealth Group during the fourth quarter valued at approximately $6,375,744,000. GAMMA Investing LLC boosted its position in shares of UnitedHealth Group by 56,142.1% during the first quarter. GAMMA Investing LLC now owns 8,295,153 shares of the healthcare conglomerate’s stock valued at $4,344,586,000 after buying an additional 8,280,404 shares during the last quarter. Raymond James Financial Inc. purchased a new stake in shares of UnitedHealth Group during the fourth quarter valued at $1,914,740,000. Amundi boosted its holdings in UnitedHealth Group by 97.2% in the fourth quarter. Amundi now owns 6,069,100 shares of the healthcare conglomerate’s stock worth $3,183,132,000 after purchasing an additional 2,991,470 shares during the last quarter. Finally, UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC boosted its stake in shares of UnitedHealth Group by 36.6% in the 4th quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 8,592,718 shares of the healthcare conglomerate’s stock worth $4,346,712,000 after buying an additional 2,301,010 shares during the last quarter. Institutional investors own 87.86% of the company’s stock.

Insider Activity at UnitedHealth Group

In related news, CEO Stephen J. Hemsley purchased 86,700 shares of the business’s stock in a transaction dated Friday, May 16th. The shares were acquired at an average cost of $288.57 per share, for a total transaction of $25,019,019.00. Following the acquisition, the chief executive officer now owns 679,493 shares of the company’s stock, valued at $196,081,295.01. The trade was a 14.63% increase in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, Director Timothy Patrick Flynn bought 1,533 shares of the business’s stock in a transaction on Wednesday, May 14th. The stock was bought at an average price of $320.80 per share, for a total transaction of $491,786.40. Following the purchase, the director now directly owns 6,033 shares of the company’s stock, valued at $1,935,386.40. The trade was a 34.07% increase in their ownership of the stock. The disclosure for this purchase can be found here. Insiders have acquired a total of 109,408 shares of company stock valued at $31,607,768 over the last ninety days. 0.33% of the stock is owned by company insiders.

Wall Street Analysts Forecast Growth

Several research analysts have issued reports on the company. KeyCorp dropped their target price on UnitedHealth Group from $450.00 to $400.00 and set an “overweight” rating on the stock in a research report on Monday. TD Cowen downgraded UnitedHealth Group from a “buy” rating to a “hold” rating and set a $308.00 target price on the stock. in a research report on Monday, May 19th. Wells Fargo & Company lowered their price objective on UnitedHealth Group from $677.00 to $351.00 and set an “overweight” rating on the stock in a research report on Wednesday, May 14th. Argus cut UnitedHealth Group from a “buy” rating to a “hold” rating in a research report on Monday, April 21st. Finally, TD Securities reaffirmed a “hold” rating and set a $308.00 price target (down previously from $520.00) on shares of UnitedHealth Group in a report on Monday, May 19th. One research analyst has rated the stock with a sell rating, seven have issued a hold rating and seventeen have issued a buy rating to the stock. According to data from MarketBeat, UnitedHealth Group currently has a consensus rating of “Moderate Buy” and an average target price of $428.43.

UnitedHealth Group Stock Performance

UNH stock opened at $300.37 on Thursday. The firm has a market cap of $272.48 billion, a price-to-earnings ratio of 19.38, a PEG ratio of 1.37 and a beta of 0.56. UnitedHealth Group Incorporated has a twelve month low of $248.88 and a twelve month high of $630.73. The business’s fifty day simple moving average is $418.00 and its two-hundred day simple moving average is $488.12. The company has a quick ratio of 0.91, a current ratio of 0.83 and a debt-to-equity ratio of 0.74.

UnitedHealth Group (NYSE:UNH) last released its quarterly earnings data on Thursday, April 17th. The healthcare conglomerate reported $7.20 EPS for the quarter, missing the consensus estimate of $7.29 by ($0.09). The firm had revenue of $109.58 billion for the quarter, compared to analysts’ expectations of $111.56 billion. UnitedHealth Group had a return on equity of 26.69% and a net margin of 3.60%. During the same quarter in the previous year, the business earned $6.91 earnings per share. Analysts predict that UnitedHealth Group Incorporated will post 29.54 earnings per share for the current year.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.